Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors

被引:10
|
作者
Zhou, Xuan [1 ]
Zhang, Xueyan [1 ]
Zhong, Tangsheng [1 ]
Zhou, Meng [1 ]
Gao, Lan [2 ,4 ]
Chen, Li [1 ,3 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Changchun, Peoples R China
[3] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China
[4] First Hosp Jilin Univ, 71 Xinmin St, Changchun 130031, Jilin, Peoples R China
关键词
breast cancer; chemotherapy-related cognitive impairment; nursing; systematic review; older adults; CHEMOBRAIN; ADULTS; AGE;
D O I
10.1111/jan.15842
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
AimsTo examine the prevalence and associated factors of chemotherapy-related cognitive impairment (CRCI) in older breast cancer survivors (BCS).DesignSystematic review.Data SourcesWe searched EMBASE, PubMed, PsychInfo, CINAHL, Cochrance Library, Web of Science, CNKI and SinoMed, without language restrictions, for studies published from the establishment of the database to September 2022.Review MethodsTwo researchers independently examined the full texts, data extraction and quality assessment, and any discrepancies were resolved through discussion with a third reviewer. Quality of evidence was assessed using the Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale.ResultsThe seven included studies showed that the estimated prevalence of CRCI in older BCS ranged from 18.6% to 27% on objective neuropsychological tests and from 7.6% to 49% on subjective cognitive assessments. The areas most affected were attention, memory, executive functioning and processing speed. CRCI was associated with 10 factors in six categories, including sociodemographic (e.g. age, education level), physiological (e.g. sleep disorders, fatigue and comorbidities), psychological (e.g. anxiety, depression), treatment modalities (e.g. chemotherapy cycles, chemotherapy regimens), genetic (e.g. APOE2, APOE4) and lifestyle factor (e.g. physical inactivity).ConclusionCRCI is multifactorial and has a relatively high prevalence. However, the results of subjective and objective cognitive examinations were inconsistent, possibly due to variations in tools used to evaluate different definitions of CRCI. Nevertheless, as there are few published studies of older BCS, this conclusion still require verification by well-designed studies in the future.ImpactWe found that the prevalence of CRCI in older adults is relatively high and multifactorial, providing evidence for further health care for this population.No Patient or Public ContributionThere was no patient or public involvement.
引用
收藏
页码:484 / 499
页数:16
相关论文
共 50 条
  • [1] Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer
    Park, Jin-Hee
    Bae, Sun Hyoung
    Jung, Yong-Sik
    Jung, Young-Mi
    JOURNAL OF KOREAN ACADEMY OF NURSING, 2015, 45 (01) : 118 - 128
  • [2] Chemotherapy-related cognitive impairment in older patients with cancer
    Loh, Kah Poh
    Janelsins, Michelle C.
    Mohile, Supriya G.
    Holmes, Holly M.
    Hsu, Tina
    Inouye, Sharon K.
    Karuturi, Meghan S.
    Kimmick, Gretchen G.
    Lichtman, Stuart M.
    Magnuson, Allison
    Whitehead, Mary I.
    Wong, Melisa L.
    Ahles, Tim A.
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (04) : 270 - 280
  • [3] Computer-Based Cognitive Training for Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
    Bail, Jennifer
    Meneses, Karen
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (05) : 504 - 509
  • [5] EXPERIENCES OF CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT IN YOUNG BREAST CANCER SURVIVORS IN JAPAN.
    Ueoka, Yuki
    Miyashita, Mika
    Kadoya, Takayuki
    Nasu, Katsumi
    ONCOLOGY NURSING FORUM, 2013, 40 (03) : E281 - E282
  • [6] Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
    Ding, Ke
    Zhang, Xiuqing
    Zhao, Jingjing
    Zuo, He
    Bi, Ziran
    Cheng, Huaidong
    INTEGRATIVE CANCER THERAPIES, 2020, 19
  • [7] Cognitive dysfunction prevalence and associated factors in older breast cancer survivors
    Crouch, Adele
    Champion, Victoria L.
    Unverzagt, Frederick W.
    Pressler, Susan J.
    Huber, Lesa
    Moser, Lyndsi R.
    Cella, David
    Von Ah, Diane
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (01) : 33 - 39
  • [8] Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia
    Alwi, Syarifah Maisarah Syed
    Narayanan, Vairavan
    Taib, Nur Aishah Mohd
    Din, Normah Che
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2021, 43 (05) : 534 - 545
  • [9] The Impact of Chemotherapy-Related Cognitive Impairment on Social Roles and Well-Being in Breast Cancer Survivors
    Bailey, Lisa R.
    Craft, Melissa
    Bert, Shannon S. C.
    Carlson, Barbara W.
    ONCOLOGY NURSING FORUM, 2024, 51 (02) : 153 - 162
  • [10] Influencing factors on chemotherapy-related cognitive impairment in patients with gastrointestinal cancer
    Kim, J. H.
    Choi, K. S.
    ANNALS OF ONCOLOGY, 2016, 27